triazoles has been researched along with Autoimmune Diseases in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Arangia, A; Cordaro, M; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Gugliandolo, E; Impellizzeri, D; Marino, Y; Siracusa, R | 1 |
Dhillon, S; Keam, SJ | 1 |
Mel'nikova, EV; Robinson, MV; Trufakin, VA | 1 |
Ferri, E; McKenna, CE; Petosa, C | 1 |
Guo, X; He, Y; Hudmon, A; Liu, S; Sun, JP; Yu, X; Zhang, ZY; Zhou, B | 1 |
Baskin, DG; Braquet, P; Goodner, CJ; Jobe, LW; Lernmark, A; Ubungen, R | 1 |
Baba, A; Fukuda, S; Makino, H; Nagai, H; Ohta, Y; Sohda, T; Tsukuda, R | 1 |
Fukuda, S; Makino, H; Ohta, Y | 1 |
Giers, G; Janzarik, H; Kempe, ER; Mueller-Eckhardt, C | 1 |
2 review(s) available for triazoles and Autoimmune Diseases
Article | Year |
---|---|
Filgotinib: First Approval.
Topics: Antirheumatic Agents; Autoimmune Diseases; Humans; Inflammation; Japan; Protein Kinase Inhibitors; Pyridines; Triazoles | 2020 |
Bromodomains: Structure, function and pharmacology of inhibition.
Topics: Acetylation; Antineoplastic Agents; Autoimmune Diseases; Azepines; Benzodiazepines; Cardiotonic Agents; Cardiovascular Diseases; Chromatin; Chromatin Assembly and Disassembly; Drug Discovery; Epigenesis, Genetic; Histones; Humans; Models, Molecular; Neoplasms; Transcription Factors; Transcription, Genetic; Triazoles | 2016 |
7 other study(ies) available for triazoles and Autoimmune Diseases
Article | Year |
---|---|
Aggravation of TGFβ1-Smad Pathway and Autoimmune Myocarditis by Fungicide (Tebuconazole) Exposure.
Topics: Animals; Autoimmune Diseases; Creatine Kinase; Fungicides, Industrial; Hydrogen Peroxide; Mammals; Myocarditis; Rats; Swine; Triazoles | 2023 |
Effects of dipeptidyl peptidase IV inhibitor sitagliptin on immunological parameters of lymphocytes in intact animals and animals with experimental autoimmune process.
Topics: Animals; Autoimmune Diseases; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Lymph Nodes; Lymphocytes; Male; Mice, Inbred CBA; Pyrazines; Sitagliptin Phosphate; Spleen; Thymus Gland; Triazoles | 2014 |
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Topics: Amino Acid Sequence; Autoimmune Diseases; Benzofurans; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Jurkat Cells; Kinetics; Lymphocyte Activation; Models, Molecular; Molecular Structure; Mutation; Phosphorylation; Phosphoserine; Protein Kinase C; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Receptors, Antigen, T-Cell; Sequence Alignment; Signal Transduction; Substrate Specificity; T-Lymphocytes; Triazoles | 2007 |
Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730.
Topics: Age Factors; Animals; Autoimmune Diseases; Azepines; Diabetes Mellitus, Type 1; Insulin; Islets of Langerhans; Male; Platelet Activating Factor; Rats; Rats, Inbred BB; Tetrazoles; Thienopyridines; Thyroid Gland; Thyroiditis, Autoimmune; Triazoles | 1993 |
Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603.
Topics: Adjuvants, Immunologic; Animals; Antirheumatic Agents; Arthritis, Experimental; Autoimmune Diseases; Cartilage; Cells, Cultured; Cytokines; Dinoprostone; Extracellular Matrix; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Quinolines; Rabbits; Radiography; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Spleen; Triazoles | 1996 |
Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Autoimmune Diseases; CD4-CD8 Ratio; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Lymphocyte Subsets; Male; Quinolines; Rats; Rats, Inbred Lew; Spleen; T-Lymphocytes; Triazoles | 1997 |
Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.
Topics: Adult; Aged; Autoimmune Diseases; Azepines; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Prospective Studies; Thrombocytopenia; Triazoles | 1990 |